Brief: AB Science SA - Announces Health Canada Issued Screening Acceptance Letter For Application Of Masitinib In Treatment Of Amyotrophic Lateral Sclerosis
27/05/2022 24:34
May 26 (Reuters) - AB Science SA ABS.PA :
* AB SCIENCE SA - ANNOUNCES HEALTH CANADA ISSUED SCREENING
ACCEPTANCE LETTER FOR APPLICATION OF MASITINIB IN TREATMENT OF
AMYOTROPHIC LATERAL SCLEROSIS
Source text for Eikon: ID:nGNX9J8qBF
Further company coverage: ABS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AB Science SA
See all newsBrief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041
Brief: AB Science Phase 1 AML Study Of AB8939 Shows 100% Partial Response Rate
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2040 In Treatment Of Sickle Cell Disease